Real World Effectiveness of Eptinezumab in Participants With Migraine
Public ClinicalTrials.gov record NCT05284019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory, Prospective, Randomized, Pragmatic Open Label Cohort Study to Evaluate the Comparative Effectiveness of Eptinezumab in the United States
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine how eptinezumab compares to other advanced preventive medications in a real-world community setting in adult participants with episodic migraine (EM) or chronic migraine (CM). These objectives include exploring the comparative effectiveness on patient reported outcomes.
Study identification
- NCT ID
- NCT05284019
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 32 participants
Conditions and interventions
Conditions
Interventions
- Eptinezumab Drug
- Erenumab Drug
- Onabotulinumtoxin-A Drug
- Fremanezumab Drug
- Galcanezumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 4, 2022 (Actual)
- Primary completion
- Feb 17, 2023 (Actual)
- Completion
- Apr 14, 2023 (Actual)
- Last update posted
- May 29, 2024
2022 – 2023
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gilbert Neurology Partners/ CCT Research | Gilbert | Arizona | 85297 | — |
| Ki Clinical Research LLC, dba New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Innovation Medical Group | Palmetto Bay | Florida | 33157 | — |
| The Headache Center | Ridgeland | Mississippi | 39157 | — |
| StudyMetrix Research | City of Saint Peters | Missouri | 63303 | — |
| North Kansas City Hospital | North Kansas City | Missouri | 64416 | — |
| Dent Neurologic Institute - Amherst | Amherst | New York | 14226 | — |
| Carolina Women's Research and Wellness Center | Durham | North Carolina | 27713 | — |
| AIM Trials, LLC | Plano | Texas | 75093 | — |
| Olympus Family Medicine/CCT Research | Salt Lake City | Utah | 84117 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05284019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2024 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05284019 live on ClinicalTrials.gov.